A new kind of medical eye drops have been submitted for approval to the American FDA which have the potential to help users read without glasses.

The drug, a pilocarpine solution, works by treating the symptoms of presbyopia, also known as near-sightedness, a condition that becomes worse as people age. Presbyopia is caused by hardening of the lens, which loses the elasticity it needs to focus from far-off objects to closer ones.
Two randomized trials of 750 patients has found the drug to be safe and effective, in general increasing the ability of the people to read by up to three lines in low light. The drops begin working 15 minutes after they are used but reach peak performance after an hour.
If approved, the drops will become the first treatment for presbyopia.

Google Maps adds new feature
- 2 hours ago
Gold prices drop as investors react to Trump’s tariff measures
- 2 hours ago

IMF delegation in Pakistan for technical support, budget discussions
- 36 minutes ago
Turkish police arrest fraudsters selling fake treasure maps for hefty fees
- an hour ago
South Korea’s top court delivers major blow to President Yoon over martial law
- 2 hours ago

Punjab sets new standard in forest management with thermal drone technology
- an hour ago
PSX sees record surge, closes lower amid global market concerns
- an hour ago
FIA nabs three agents involved in sea route smuggling to Europe
- 2 hours ago

John Cena reveals suffering skin cancer twice
- 2 hours ago
Karachi cop booked, arrested for using derogatory language against President Zardari
- an hour ago

Punjab Police armors vehicles with bulletproofing for enhanced security
- 3 hours ago

Ohtani's walk-off pushes Dodgers to historic 8-0
- 24 minutes ago